Rice Hall James & Associates LLC Purchases New Position in Teleflex Incorporated $TFX

Rice Hall James & Associates LLC acquired a new stake in Teleflex Incorporated (NYSE:TFX) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 4,558 shares of the medical technology company’s stock, valued at approximately $578,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Empowered Funds LLC lifted its stake in shares of Teleflex by 15.8% in the 1st quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after acquiring an additional 230 shares during the last quarter. Jane Street Group LLC grew its position in Teleflex by 42.6% during the 1st quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock worth $877,000 after acquiring an additional 1,895 shares during the last quarter. American Century Companies Inc. grew its position in Teleflex by 32.7% during the 2nd quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock worth $1,614,000 after acquiring an additional 3,360 shares during the last quarter. Invesco Ltd. increased its holdings in Teleflex by 1.2% in the 2nd quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock worth $16,040,000 after purchasing an additional 1,659 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its holdings in Teleflex by 108.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock worth $119,000 after purchasing an additional 521 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Trading Down 0.6%

Shares of TFX stock opened at $132.26 on Wednesday. The stock has a market cap of $5.60 billion, a price-to-earnings ratio of -5.68, a PEG ratio of 0.91 and a beta of 0.81. The stock has a 50-day moving average of $132.33 and a 200-day moving average of $124.20. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $145.00.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.48. The company had revenue of $570.33 million during the quarter, compared to the consensus estimate of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The firm’s revenue was up 28.9% compared to the same quarter last year. During the same period last year, the company earned $3.73 earnings per share. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, equities research analysts forecast that Teleflex Incorporated will post 7.26 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be issued a dividend of $0.34 per share. The ex-dividend date is Friday, August 14th. This represents a $1.36 annualized dividend and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is presently -5.84%.

Analysts Set New Price Targets

TFX has been the topic of several research reports. BMO Capital Markets assumed coverage on Teleflex in a report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price target on the stock. Zacks Research upgraded shares of Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Needham & Company LLC lifted their target price on shares of Teleflex from $147.00 to $159.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Mizuho lifted their target price on shares of Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 15th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a report on Wednesday, June 24th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Teleflex has an average rating of “Hold” and an average price target of $151.80.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.